Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel

NYT > Top Stories Rebecca Robbins and Carl ZimmerThe treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation. December 01, 2021 at 02:23AM https://ift.tt/3o9frsb